QQ客服 官方微博 反馈留言

浏览/检索结果: 共2条，第1-2条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs) 期刊论文 ANNALS OF PALLIATIVE MEDICINE, 2021 作者:  Si, Jinfei;  Gu, Xiaodong;  Wang, Wenxian;  Ying, Shenpeng;  Song, Zhengbo 收藏  |  浏览/下载：59/0  |  提交时间：2022/02/14 Epidermal growth factor receptor (EGFR)  uncommon mutation  compound mutation  double uncommon mutation  lung adenocarcinoma (lung AC)   SPOCK1 contributes to the third-generation EGFR tyrosine kinase inhibitors resistance in lung cancer. 期刊论文 Journal of cellular biochemistry, 2019 作者:  Yujuan Gao;  Min Yu;  Miao Ma;  Yi Zhuang;  Xiaohua Qiu 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/17 SPOCK1  non-small cell lung cancer (NSCLC)  third-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) resistance